Market narrative
Move between stock news, official company releases, crypto, and FX without losing the path back to ticker research.
GE's commercial engines unit surges on services, spare parts and LEAP deliveries, while major orders support its 2026 growth outlook.
Stocks
PLTR's AI-driven growth, rising margins and strong cash flow support its rally, but a steep valuation raises the bar for further gains.
Beam Therapeutics posts a wider-than-expected Q2 loss. Revenues also miss estimates as it advances multiple genome-editing programs with key clinical milestones ahead.
Nvidia (NVDA) shares climbed about 3% on Wednesday as SpaceX selected the chipmaker as its sole AI hardware supplier for future infrastructure, while other majo
British American Tobacco p.l.c. (BTI) Q2 2026 Earnings Call Transcript
UPS and Fluor deserve more attention from value-seeking investors.
Google's AI divisions are getting shuffled, the search giant announced on Wednesday. Jeff Dean, the longtime chief scientist, is leaving after 27 years to start his own company.
BlackRock Enhanced Large Cap Core Fund trades at a slight 1% premium, making new purchases less attractive but not warranting a "Sell." I continue to "Hold" CII for its 7.32% yield and monthly distributions but favor alternatives for new capital due to its wider discount. CII's portfolio is concentrated in 37 holdings, overweight tech, and relies on capital gains and options writing to fund distributions.
EOG's Q2 earnings beat estimates as higher oil prices and a 24.4% production gain fueled a 57.4% revenue surge and strong free cash flow.
Boston Scientific ( BSX ) manufactures medical devices and products used in various interventional medical specialties worldwide, including cardiovascular and surgical categories. On July 29, BSX reported revenue of $5.44 billion for their June quarter, up 7.5% over the same period last year.
Iron Mountain tops Q2 estimates as data centers, ALM and digital growth fuel stronger results, prompting a higher 2026 AFFO outlook.
SRE's Q2 results are likely to reflect rate-base growth, Oncor benefits and initial ECA LNG revenues, with earnings and sales projected to rise.
Assurant beats Q2 earnings estimates as Global Lifestyle and Global Housing deliver strong growth, boosting revenues and prompting a higher 2026 outlook.
Global Indemnity Group NASDAQ: GBLI reported second-quarter net income of $11.1 million, up 8% from $10.3 million a year earlier, as the insurer cited continued strength in loss performance, higher investment income and growth in several core businesses.
Gladstone Capital NASDAQ: GLAD reported third-quarter net investment income of $11 million, or $0.49 per share, for the quarter ended June 30, 2026, as higher interest income was offset by lower one-time prepayment fee income and increased borrowing costs.
Greenlight Capital Re NASDAQ: GLRE reported a second-quarter net loss of $29.6 million, or $0.89 per diluted share, as investment losses in its Solasglas portfolio and catastrophe and large-loss provisions weighed on results.
Ferroglobe NASDAQ: GSM reported higher shipments, revenue, adjusted EBITDA and free cash flow in the second quarter of 2026, as increased silicon metal volumes and stronger fixed-cost absorption helped offset continued pricing pressure from imports.
Horizon Technology Finance NASDAQ: HRZN said its second-quarter net asset value declined primarily because of write-downs tied to one portfolio company, even as the business development company expanded its debt investment portfolio for a third consecutive quarter and reported a larger committed backlog following its April merger with Monroe Capital Corporation.
Icahn Enterprises NASDAQ: IEP reported a second-quarter 2026 net loss attributable to the company of $355 million, or $0.52 per depositary unit, compared with a $165 million loss, or $0.30 per unit, a year earlier. Adjusted EBITDA attributable to IEP was a loss of $134 million, compared with adjusted EBITDA of $40 million in the prior-year quarter.
Trump promised to bring factory construction roaring back, but the numbers heading into 2027 tell a story his campaign rallies never did, and current production data makes the picture even more complicated.
